Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis

Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New-Onset Rheumatoid Arthritis: A Nested Case-Control Study

(2015) Ängla Mantel et al.   Arthritis & Rheumatology

Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events

(2015) D. H. Solomon et al.   Arthritis & Rheumatology

How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?

(2014) H Wadström et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

(2014) Lotta Ljung et al.   ARTHRITIS RESEARCH & THERAPY

Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs

(2013) Daniel H. Solomon et al.   AMERICAN JOURNAL OF MEDICINE

Tumor Necrosis Factor α Inhibitor Use and Decreased Risk for Incident Coronary Events in Rheumatoid Arthritis

(2013) Androniki Bili et al.   ARTHRITIS CARE & RESEARCH

Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index

(2012) Daniel Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies

(2012) Juan Antonio Avina-Zubieta et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

(2011) Lotta Ljung et al.   ARTHRITIS AND RHEUMATISM

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

(2011) David T. Felson et al.   ARTHRITIS AND RHEUMATISM

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE

(2011) Deborah P. M. Symmons et al.   Nature Reviews Rheumatology

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study

(2011) Lena Innala et al.   ARTHRITIS RESEARCH & THERAPY

Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register

(2010) M. Neovius et al.   ANNALS OF THE RHEUMATIC DISEASES

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

(2010) J. D. Greenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity

(2010) D. H. Solomon et al.   ANNALS OF THE RHEUMATIC DISEASES

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Reg

(2010) Saedis Saevarsdottir et al.   ARTHRITIS AND RHEUMATISM

Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis

(2010) Ziyad Al-Aly et al.   Translational Research

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies

(2009) Roland Klingenberg et al.   EUROPEAN HEART JOURNAL

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis

(2008) Frederick Wolfe et al.   ARTHRITIS AND RHEUMATISM

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

(2008) Antonio Naranjo et al.   ARTHRITIS RESEARCH & THERAPY

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

(2007) A Gonzalez et al.   ANNALS OF THE RHEUMATIC DISEASES